Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier

Molecular Pharmaceutics

Volumn 2, Issue 1, 2005, Pages 22-28

  Cui, Zhengrong ^a,b   Han, Su Ji ^a   Vangasseri, Dileep Padinjarae ^a   Huang, Leaf ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Cationic lipid; Costimulatory molecules; Plasmid DNA; TNF lymph nodes

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; B7 ANTIGEN; CANCER VACCINE; CD86 ANTIGEN; CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOLOGICAL ADJUVANT; LIPOSOME; LUCIFERASE; NANOPARTICLE; PLASMID DNA; POLYCATION; PROTAMINE; PROTEIN E6; PROTEIN E7; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; FEMALE; IMMUNOSTIMULATION; LYMPH NODE; LYMPHOID TISSUE; MOUSE; NONHUMAN; ONCOGENE H RAS; PARTICLE SIZE; PRIORITY JOURNAL; SPLEEN CELL; SUBCUTANEOUS TISSUE TUMOR; ZETA POTENTIAL;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CELL LINE; CHOLESTEROL; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; DRUG COMBINATIONS; FATTY ACIDS, MONOUNSATURATED; FEMALE; IMMUNIZATION; INTERFERON TYPE II; LIPOSOMES; LUCIFERASES; LYMPH NODES; LYMPHOID TISSUE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NANOSTRUCTURES; OXAZOLES; PLASMIDS; PROTAMINES; PYRIMIDINONES; QUATERNARY AMMONIUM COMPOUNDS; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, DNA;

EID: 14644400451     PISSN: 15438384     EISSN: None     Source Type: Journal    
DOI: 10.1021/mp049907k     Document Type: Article

References (25)

1. Plotkin, S. A. Vaccines, vaccination, and vaccinology. J. Infect. Dis. 2003, 187 (9), 1349-1359.
2. Dileo, J.; Banerjee, R.; Whitmore, M.; Nayak, J. V.; Falo, L. D.; Huang, L. Lipid-protamine-DNA-mediated antigen delivery to antigen-presenting cells results in enhanced anti-tumor immune responses. Mol. Ther. 2003, 7 (5), 640-648.
3. Li, S.; Rizzo, M. A.; Bhattacharya, S.; Huang, L. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther. 1998, 5 (7), 930-937.
4. Li, S.; Huang, L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 1997, 4(9), 891-900.
5. Tan, Y.; Li, S.; Pitt, B. R.; Huang, L. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum. Gene Ther. 1999, 10 (13), 2153-2161.
6. Whitmore, M. M.; Li, S.; Falo, L., Jr.; Huang, L. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses. Cancer Immunol. Immunother. 2001, 50 (10), 503-514.
7. Hemmi, H.; Takeuchi, O.; Kawai, T.; Kaisho, T.; Sato, S.; Sanjo, H.; Matsumoto, M.; Hoshino, K.; Wagner, H.; Takeda, K.; Akira, S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408 (6813), 740-745.
8. Wagner, H. Toll meets bacterial CpG-DNA. Immunity 2001, 14 (5), 499-502.
9. Okada, N.; Saito, T.; Mori, K.; Masunaga, Y.; Fujii, Y.; Fujita, J.; Fujimoto, K.; Nakanishi, T.; Tanaka, K.; Nakagawa, S.; Mayumi, T.; Fujita, T.; Yamamoto, A. Effects of lipofectin-antigen complexes on major histocompatibility complex class I-restricted antigen presentation pathway in murine dendritic cells and on dendritic cell maturation. Biochim. Biophys. Acta 2001, 7527 (3), 97-101.
10. Mendoza, L.; Bubenik, J.; Simova, J.; Jandlova, T.; Vonka, V.; Mikyskova, R. Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours. Int. J. Oncol. 2003, 23 (1), 243-247.
11. Ochsenbein, A. F.; Klenerman, P.; Karrer, U.; Ludewig, B.; Pericin, M.; Hengartner, H.; Zinkernagel, R. M. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc. Natl. Acad. Sci. U.S.A. 1999, 96 (5), 2233-2238.
12. Zinkernagel, R. M.; Ehl, S.; Aichele, P.; Oehen, S.; Kundig, T.; Hengartner, H. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: A geographical view of immune reactivity. Immunol. Rev. 1997, 756, 199-209.
13. Celluzzi, C. M.; Mayordomo, J. I.; Storkus, W. J.; Lotze, M. T.; Falo, L. D., Jr. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 1996, 183 (1), 283-287.
14. Armant, M. A.; Fenton, M. J. Toll-like receptors: A family of pattern-recognition receptors in mammals. Genome Biol. 2002, 3 (8), 3011.
15. Medzhitov, R.; Janeway, C. A., Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002, 296 (5566), 298-300.
16. De Smedt, T.; Pajak, B.; Muraille, E.; Lespagnard, L.; Keinen, E.; De Baetselier, P.; Urbain, J.; Leo, O.; Moser, M. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 1996, 184 (4), 1413-1424.
17. Banchereau, J.; Steinman, R. M. Dendritic cells and the control of immunity. Nature 1998, 392 (6673), 245-252.
18. Akira, S.; Takeda, K.; Kaisho, T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat. Immunol. 2001, 2 (8), 675-680.
19. Zhang, D.; Zhang, G.; Hayden, M. S.; Greenblatt, M. B.; Bussey, C.; Flavell, R. A.; Ghosh, S. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004, 303 (5663), 1522-1526.
20. Kaisho, T.; Akira, S. Toll-like receptors as adjuvant receptors. Biochim. Biophys. Acta 2002, 1589 (1), 1-13.
21. Muzio, M.; Ni, J.; Feng, P.; Dixit, V. M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997, 278 (5343), 1612-1615.
22. Heil, F.; Hemmi, H.; Hochrein, H.; Ampenberger, F.; Kirschning, C.; Akira, S.; Lipford, G.; Wagner, H.; Bauer, S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303 (5663), 1526-1529.
23. Gurunathan, S.; Wu, C. Y.; Freidag, B. L.; Seder, R. A. DNA vaccines: A key for inducing long-term cellular immunity. Curr. Opin. Immunol. 2000, 12 (4), 442-447.
24. Hacker, H.; Mischak, H.; Miethke, T.; Liptay, S.; Schmid, R.; Sparwasser, T.; Heeg, K.; Lipford, G. B.; Wagner, H. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 1998, 17 (21), 6230-6240.
25. Kaisho, T.; Takeuchi, O.; Kawai, T.; Hoshino, K.; Akira, S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 2001, 166 (9), 5688-5694.